Medifoxamine (Cledial, Gerdaxyl) is an antidepressant which acts as a dopamine reuptake inhibitor and agonist at the 5-HT2A and 5-HT2C receptors. It was used mainly in France, but was withdrawn following problems with hepatotoxicity.